×
Estimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey. PDF
$ 40.00
Estimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey. PDF quantity
$ 40.00
×
Switching to Olanzapine After Unsuccessful Treatment With Risperidone During the First Episode of Schizophrenia: An Open-Label Trial PDF
$ 40.00
Switching to Olanzapine After Unsuccessful Treatment With Risperidone During the First Episode of Schizophrenia: An Open-Label Trial PDF quantity
$ 40.00
×
Prevalence of Attenuated Psychotic Symptoms and Their Relationship With DSM-IV Diagnoses in a General Psychiatric Outpatient Clinic PDF
$ 40.00
Prevalence of Attenuated Psychotic Symptoms and Their Relationship With DSM-IV Diagnoses in a General Psychiatric Outpatient Clinic PDF quantity
$ 40.00
×
National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey PDF
$ 40.00
National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey PDF quantity
$ 40.00
×
The Mental Health Characteristics of Pregnant Women With Depressive Symptoms Identified by the Edinburgh Postnatal Depression Scale PDF
$ 40.00
The Mental Health Characteristics of Pregnant Women With Depressive Symptoms Identified by the Edinburgh Postnatal Depression Scale PDF quantity
$ 40.00
×
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in Children and Adolescents With Tourette's Disorder PDF
$ 40.00
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in Children and Adolescents With Tourette's Disorder PDF quantity
$ 40.00
×
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF
$ 40.00
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF quantity
$ 40.00
×
Pharmacologic Treatment of Anxiety Disorders in 1989 Versus 1996: Results From the Harvard/Brown Anxiety Disorders Research Program PDF
$ 40.00
Pharmacologic Treatment of Anxiety Disorders in 1989 Versus 1996: Results From the Harvard/Brown Anxiety Disorders Research Program PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart